Advancements in AI for Breast Cancer Screening and Diagnosis
TL;DR
A new AI-based software developed at WashU Medicine, called Prognosia Breast, has received FDA Breakthrough Device designation for its ability to analyze mammograms and provide a more accurate five-year breast cancer risk prediction, potentially improving early detection and prevention efforts.
Topics:healthhealthcare#ai#breast-cancer#fda-breakthrough-device#healthcare#mammogram-analysis#risk-prediction
- AI-based breast cancer risk technology receives FDA Breakthrough Device designation WashU Medicine
- Team of AI Agents for Improved Mammography Screening Elektroniknet
- AI Enhances Detection of Missed Breast Cancers on Screening Tomosynthesis The ASCO Post
- Sahar Mansour: How We Approach Screening, Diagnosis and Follow-Up in Breast Cancer Through AI Oncodaily
- Risk inventory and mitigation actions for AI in medical imaging—a qualitative study of implementing standalone AI for screening mammography BMC Health Services Research
Want the full story? Read the original reporting
Read on WashU Medicine